Resveratrol suppresses melanoma growth by promoting autophagy through inhibiting the PI3K/AKT/mTOR signaling pathway Retraction in /10.3892/etm.2024.12668

Gong,Changhua; Xia,Honglei

doi:10.3892/etm.2019.8359

Resveratrol suppresses melanoma growth by promoting autophagy through inhibiting the PI3K/AKT/mTOR signaling pathway

Retraction in: /10.3892/etm.2024.12668

Authors:
- Changhua Gong
- Honglei Xia
View Affiliations

Affiliations: Department of Pharmacy, People's Hospital of Zhenhai, Ningbo, Zhejiang 315202, P.R. China
Published online on: December 20, 2019 https://doi.org/10.3892/etm.2019.8359
Pages: 1878-1886
Copyright: © Gong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resveratrol (RV) is a natural polyphenolic phytoalexin derived from peanuts, red grape skins and red wine, and has been demonstrated to alleviate multiple types of malignancies. However, how RV achieves this in melanoma is unknown. The aim of present study was to investigate the role of RV in melanoma, using Cell Counting Kit‑8, flow cytometry and western blot analysis. RV inhibited melanoma cell viability, migration and invasion counteracting melanoma progression. In addition, proteins associated with autophagy, including Beclin 1 and microtubule‑associated protein 1A/1B‑light chain 3 (LC3)‑II/I, were upregulated, whereas p62 expression was downregulated in RV‑treated cells. The number of LC3+ puncta, which can be applied to represent autophagosome formation, increased following RV treatment, suggesting that RV may trigger autophagy in melanoma cells. Treatment with the autophagy inhibitor, 3‑methyladenine, reversed the RV‑dependent inhibition of viability, migration and invasion of melanoma cells. RV treatment also reduced the ratios of phosphorylated (p)‑AKT/AKT and p‑mTOR/mTOR in melanoma cells. In conclusion, these findings suggested that RV may inhibit the viability and migration of melanoma cells through inhibiting the AKT/mTOR pathway, thus triggering autophagy. This indicated that RV may serve as an innovative therapeutic for melanoma treatment.

View Figures

View References

1	Falletta P, Sanchez-Del-Campo L, Chauhan J, Effern M, Kenyon A, Kershaw CJ, Siddaway R, Lisle R, Freter R, Daniels MJ, et al: Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. Genes Dev. 31:18–33. 2017. View Article : Google Scholar : PubMed/NCBI
2	Jha S, Morris EJ, Hruza A, Mansueto MS, Schroeder GK, Arbanas J, McMasters D, Restaino CR, Dayananth P, Black S, et al: Dissecting therapeutic resistance to ERK inhibition. Mol Cancer Ther. 15:548–559. 2016. View Article : Google Scholar : PubMed/NCBI
3	Rastrelli M, Tropea S, Rossi CR and Alaibac M: Melanoma: Epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 28:1005–1011. 2014.PubMed/NCBI
4	Boyle GM: Therapy for metastatic melanoma: An overview and update. Expert Rev Anticancer Ther. 11:725–737. 2011. View Article : Google Scholar : PubMed/NCBI
5	Oz B, Yildirim A, Yolbas S, Celik ZB, Etem EO, Deniz G, Akin M, Akar ZA, Karatas A and Koca SS: Resveratrol inhibits Src tyrosine kinase, STAT3, and Wnt signaling pathway in collagen induced arthritis model. Biofactors. 45:69–74. 2019. View Article : Google Scholar : PubMed/NCBI
6	Suh J, Kim DH and Surh YJ: Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch Biochem Biophys. 643:62–71. 2018. View Article : Google Scholar : PubMed/NCBI
7	Jhaveri A, Luther E and Torchilin V: The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: Implications for targeting tumour-initiating cells. J Drug Target. 27:601–613. 2019. View Article : Google Scholar : PubMed/NCBI
8	Zadi Heydarabad M, Nikasa M, Vatanmakanian M, Azimi A and Farshdousti Hagh M: Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective. J Cell Biochem. 119:4890–4896. 2018. View Article : Google Scholar : PubMed/NCBI
9	Fröjdö S, Cozzone D, Vidal H and Pirola L: Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J. 406:511–518. 2007. View Article : Google Scholar : PubMed/NCBI
10	Gwak H, Haegeman G, Tsang BK and Song YS: Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells. Mol Carcinog. 54:1529–1540. 2015. View Article : Google Scholar : PubMed/NCBI
11	Trincheri NF, Follo C, Nicotra G, Peracchio C, Castino R and Isidoro C: Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis. 29:381–389. 2008. View Article : Google Scholar : PubMed/NCBI
12	Venkatadri R, Muni T, Iyer AK, Yakisich JS and Azad N: Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death. Cell Death Dis. 7:e21042016. View Article : Google Scholar : PubMed/NCBI
13	Yang J, Chen Q, Tian S, Song S, Liu F, Wang Q and Fu Z: The role of 1,25-dyhydroxyvitamin D3 in mouse liver ischemia reperfusion injury: Regulation of autophagy through activation of MEK/ERK signaling and PTEN/PI3K/Akt/mTORC1 signaling. Am J Transl Res. 7:2630–2645. 2015.PubMed/NCBI
14	Pi H, Li M, Zou L, Yang M, Deng P, Fan T, Liu M, Tian L, Tu M, Xie J, et al: AKT inhibition-mediated dephosphorylation of TFE3 promotes overactive autophagy independent of MTORC1 in cadmium-exposed bone mesenchymal stem cells. Autophagy. 15:565–582. 2019. View Article : Google Scholar : PubMed/NCBI
15	Su Y, Lu J, Gong P, Chen X, Liang C and Zhang J: Rapamycin induces autophagy to alleviate acute kidney injury following cerebral ischemia and reperfusion via the mTORC1/ATG13/ULK1 signaling pathway. Mol Med Rep. 18:5445–5454. 2018.PubMed/NCBI
16	Grandèr D and Panaretakis T: Autophagy: Cancer therapy's friend or foe? Future Med Chem. 2:285–297. 2010. View Article : Google Scholar : PubMed/NCBI
17	Livesey KM, Tang D, Zeh HJ and Lotze MT: Not just nuclear proteins: ‘Novel’ autophagy cancer treatment targets-p53 and HMGB1. Curr Opin Investig Drugs. 9:1259–1263. 2008.PubMed/NCBI
18	Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Sotgia F and Lisanti MP: Warburg meets autophagy: Cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal. 16:1264–1284. 2012. View Article : Google Scholar : PubMed/NCBI
19	Verykiou S, Alexander M, Edwards N, Plummer R, Chaudhry B, Lovat PE and Hill DS: Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma. Br J Dermatol. 180:346–356. 2019. View Article : Google Scholar : PubMed/NCBI
20	Tan RH, Wang F, Fan CL, Zhang XH, Zhao JS, Zhang JJ, Yang Y, Xi Y, Zou ZQ and Bu SZ: Algal oil rich in n-3 polyunsaturated fatty acids suppresses B16F10 melanoma lung metastasis by autophagy induction. Food Funct. 9:6179–6186. 2018. View Article : Google Scholar : PubMed/NCBI
21	Wu X, Yu J, Yan J, Dai J, Si L, Chi Z, Sheng X, Cui C, Ma M, Tang H, et al: PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro. Cancer Biol Ther. 19:584–589. 2018. View Article : Google Scholar : PubMed/NCBI
22	Wang H, Peng Y, Wang J, Gu A, Li Q, Mao D and Guo L: Effect of autophagy on the resveratrol-induced apoptosis of ovarian cancer SKOV3 cells. J Cell Biochem. Nov 18–2018.(Epub ahead of print).
23	Liu D, He B, Lin L, Malhotra A and Yuan N: Potential of curcumin and resveratrol as biochemical and biophysical modulators during lung cancer in rats. Drug Chem Toxicol. 42:328–334. 2019. View Article : Google Scholar : PubMed/NCBI
24	Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, et al: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway. Int J Mol Med. 43:630–640. 2019.PubMed/NCBI
25	Lei MJ, Dong Y, Sun CX and Zhang XH: Resveratrol inhibits proliferation, promotes differentiation and melanogenesis in HT-144 melanoma cells through inhibition of MEK/ERK kinase pathway. Microb Pathog. 111:410–413. 2017. View Article : Google Scholar : PubMed/NCBI
26	Kim SE, Shin SH, Lee JY, Kim CH, Chung IK, Kang HM, Park HR, Park BS and Kim IR: Resveratrol induces mitochondrial apoptosis and inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma cells. Nutr Cancer. 70:125–135. 2018. View Article : Google Scholar : PubMed/NCBI
27	Wright C, Iyer AKV, Yakisich JS and Azad N: Anti-tumorigenic effects of resveratrol in lung cancer cells through modulation of c-FLIP. Curr Cancer Drug Targets. 17:669–680. 2017. View Article : Google Scholar : PubMed/NCBI
28	Nazim UM and Park SY: Attenuation of autophagy flux by 6-shogaol sensitizes human liver cancer cells to TRAIL-induced apoptosis via p53 and ROS. Int J Mol Med. 43:701–708. 2019.PubMed/NCBI
29	Zhou GZ, Shi YY, Wei LL and Sun GC: Autophagy induction and antiproliferative effect of a novel curcumin derivative MOMI-1 on the human lung cancer cells A549. J Biochem Mol Toxicol. 33:e222802019. View Article : Google Scholar : PubMed/NCBI
30	Nguyen TD, Shaid S, Vakhrusheva O, Koschade SE, Klann K, Thölken M, Baker F, Zhang J, Oellerich T, Sürün D, et al: Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood. 133:168–179. 2019. View Article : Google Scholar : PubMed/NCBI
31	Ge D, Gao J, Han L, Li Y, Liu HH, Yang WC, Chang F, Liu J, Yu M and Zhao J: Novel effects of sphingosylphosphorylcholine on the apoptosis of breast cancer via autophagy/AKT/p38 and JNK signaling. J Cell Physiol. 234:11451–11462. 2019. View Article : Google Scholar : PubMed/NCBI
32	Cordani M and Somoza Á: Targeting autophagy using metallic nanoparticles: A promising strategy for cancer treatment. Cell Mol Life Sci. 76:1215–1242. 2019. View Article : Google Scholar : PubMed/NCBI
33	Koustas E, Sarantis P, Papavassiliou AG and Karamouzis MV: Upgraded role of autophagy in colorectal carcinomas. World J Gastrointest Oncol. 10:367–369. 2018. View Article : Google Scholar : PubMed/NCBI
34	Li WD, Li NP, Song DD, Rong JJ, Qian AM and Li XQ: Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK/mTOR/autophagy pathway. Int J Mol Med. 39:1262–1268. 2017. View Article : Google Scholar : PubMed/NCBI
35	Zhang N, Zhang J, Tan YQ, Du GF, Lu R and Zhou G: Activated Akt/mTOR-autophagy in local T cells of oral lichen planus. Int Immunopharmacol. 48:84–90. 2017. View Article : Google Scholar : PubMed/NCBI
36	Shi X, Yang L, Xie J, Zhao Y, Cong J, Li Z, Li H, Cheng X and Fan J: UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathway. Mol Med Rep. 18:3382–3388. 2018.PubMed/NCBI
37	Kumar D, Shankar S and Srivastava RK: Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett. 343:179–189. 2014. View Article : Google Scholar : PubMed/NCBI
38	Chiu HY, Tsay YG and Hung SC: Involvement of mTOR-autophagy in the selection of primitive mesenchymal stem cells in chitosan film 3-dimensional culture. Sci Rep. 7:101132017. View Article : Google Scholar : PubMed/NCBI